Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down‐regulation of c‐Met
Abstract Hematologic and neurological expression 1 (HN1) has been reported to involved in certain cancers, but its role in hepatocellular carcinoma (HCC) is largely unknown. The contribution of HN1 to HCC progression was investigated in the present study. We found that HN1 was significantly up‐regul...
Main Authors: | Jia‐Jie Chen, Xu Sun, Qi‐Qi Mao, Xiao‐Yun Jiang, Xian‐Guang Zhao, Wei‐Jia Xu, Liang Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/kjm2.12156 |
Similar Items
-
MET Expression Level in Lung Adenocarcinoma Loosely Correlates with <i>MET</i> Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
by: Wei Yin, et al.
Published: (2022-05-01) -
hnRNP A1: The Swiss Army Knife of Gene Expression
by: Massimo Caputi, et al.
Published: (2013-09-01) -
Increase in hnRNPA1 Expression Suffices to Kill Motor Neurons in Transgenic Rats
by: Bo Huang, et al.
Published: (2023-11-01) -
Correlation of MET and PD-L1 Expression in Malignant Melanoma
by: Kyu Young Song, et al.
Published: (2020-07-01) -
Responses to the Tepotinib in Gastric Cancers with MET Amplification or MET Exon 14 Skipping Mutations and High Expression of Both PD-L1 and CD44
by: Sung-Hwa Sohn, et al.
Published: (2022-07-01)